Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Genius Group Limited stock logo
GNS
Genius Group
$0.86
-4.3%
$0.93
$0.21
$1.92
$75.60M10.734.66 million shs1.40 million shs
NewMarket Corporation stock logo
NEU
NewMarket
$789.88
+0.8%
$806.86
$480.00
$875.97
$7.42B0.4580,266 shs53,013 shs
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
$327.03
+2.2%
$322.88
$170.99
$355.30
$35.84B0.31406,608 shs145,433 shs
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Genius Group Limited stock logo
GNS
Genius Group
0.00%-7.22%-17.43%-42.68%+13.92%
NewMarket Corporation stock logo
NEU
NewMarket
0.00%-7.32%-6.61%+7.11%+49.11%
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
0.00%-6.91%-1.31%+26.95%+32,009,999,900.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Genius Group Limited stock logo
GNS
Genius Group
$0.86
-4.3%
$0.93
$0.21
$1.92
$75.60M10.734.66 million shs1.40 million shs
NewMarket Corporation stock logo
NEU
NewMarket
$789.88
+0.8%
$806.86
$480.00
$875.97
$7.42B0.4580,266 shs53,013 shs
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
$327.03
+2.2%
$322.88
$170.99
$355.30
$35.84B0.31406,608 shs145,433 shs
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Genius Group Limited stock logo
GNS
Genius Group
0.00%-7.22%-17.43%-42.68%+13.92%
NewMarket Corporation stock logo
NEU
NewMarket
0.00%-7.32%-6.61%+7.11%+49.11%
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
0.00%-6.91%-1.31%+26.95%+32,009,999,900.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Genius Group Limited stock logo
GNS
Genius Group
0.00
N/AN/AN/A
NewMarket Corporation stock logo
NEU
NewMarket
3.00
BuyN/AN/A
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
2.90
Moderate Buy$340.304.06% Upside

Current Analyst Ratings Breakdown

Latest CUV, GNS, NEU, and ONC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/8/2025
NewMarket Corporation stock logo
NEU
NewMarket
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy (B+)
10/8/2025
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOverweight$345.00 ➝ $385.00
10/8/2025
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
9/27/2025
NewMarket Corporation stock logo
NEU
NewMarket
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy (B+)
9/27/2025
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
9/18/2025
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHoldStrong-Buy
9/18/2025
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageOverweight$385.00
8/7/2025
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOutperform$349.00 ➝ $364.00
8/7/2025
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
Guggenheim
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$350.00 ➝ $365.00
7/17/2025
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOverweight$321.00 ➝ $345.00
7/16/2025
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOutperform$311.00 ➝ $349.00
(Data available from 10/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Genius Group Limited stock logo
GNS
Genius Group
$7.91M9.56N/AN/A$1.23 per share0.70
NewMarket Corporation stock logo
NEU
NewMarket
$2.79B2.66$60.85 per share12.98$152.33 per share5.19
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
$3.81B9.41N/AN/A$34.10 per share9.59
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Genius Group Limited stock logo
GNS
Genius Group
-$24.88MN/A0.00N/AN/AN/AN/AN/AN/A
NewMarket Corporation stock logo
NEU
NewMarket
$462.41M$50.4515.66N/A17.28%32.25%15.10%10/30/2025 (Confirmed)
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
-$644.79M-$1.73N/A460.61N/A-3.89%-1.22%-0.72%N/A

Latest CUV, GNS, NEU, and ONC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/6/2025Q2 2025
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
$0.48$0.84+$0.36$0.84$1.24 billion$1.32 billion
7/30/2025Q2 2025
NewMarket Corporation stock logo
NEU
NewMarket
N/A$11.84N/A$11.84N/A$698.51 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Genius Group Limited stock logo
GNS
Genius Group
N/AN/AN/AN/AN/A
NewMarket Corporation stock logo
NEU
NewMarket
$11.001.39%N/A21.80%7 Years
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
N/AN/AN/AN/AN/A

Latest CUV, GNS, NEU, and ONC Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/7/2025
NewMarket Corporation stock logo
NEU
NewMarket
quarterly$2.751.32%9/15/20259/15/202510/1/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Genius Group Limited stock logo
GNS
Genius Group
0.07
2.16
2.12
NewMarket Corporation stock logo
NEU
NewMarket
0.52
2.66
1.43
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
0.04
1.95
1.72

Institutional Ownership

CompanyInstitutional Ownership
Genius Group Limited stock logo
GNS
Genius Group
14.28%
NewMarket Corporation stock logo
NEU
NewMarket
61.09%
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
48.55%

Insider Ownership

CompanyInsider Ownership
Genius Group Limited stock logo
GNS
Genius Group
51.19%
NewMarket Corporation stock logo
NEU
NewMarket
19.10%
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
6.62%
CompanyEmployeesShares OutstandingFree FloatOptionable
Genius Group Limited stock logo
GNS
Genius Group
48087.81 million42.86 millionNot Optionable
NewMarket Corporation stock logo
NEU
NewMarket
2,0609.40 million7.60 millionOptionable
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
11,000109.60 million102.34 millionN/A

Recent News About These Companies

BeOne Medicines (NASDAQ:ONC) SVP Sells $3,739,118.40 in Stock
BeOne Medicines (NASDAQ:ONC) Shares Gap Down - Should You Sell?
Guggenheim Keeps Their Buy Rating on BeOne Medicines (ONC)
BeOne Medicines (NASDAQ:ONC) Upgraded at Wall Street Zen
Here’s Why BeOne Medicines Ltd. (ONC) Declined in Q2

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Genius Group stock logo

Genius Group NYSEAMERICAN:GNS

$0.86 -0.04 (-4.33%)
Closing price 04:10 PM Eastern
Extended Trading
$0.87 +0.01 (+1.16%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Genius Group Limited, through its subsidiaries, provides entrepreneur education system business development tools and management consultancy services to entrepreneurs and entrepreneur resorts. The company operates through two segments, Education and Campus. It develops comprehensive entrepreneurial education curriculum with a full suite of tools for student learning and faculty earning. The company also owns entrepreneur resorts in Bali and South Africa, which run entrepreneur retreats and workshops; and Genius Café, an entrepreneur beach club in Bali, as well as Genius Central, an entrepreneur co-working hub in Singapore. In addition, it offers home childcare and investment education services; operates entrepreneur education campus that provides a range of programs from pre-primary through primary school, secondary school, and vocational college; and provides career-focused on-campus and online programs at the master's, bachelor's and associate degree level, as well as certificate and continuing education programs. The company operates in Europe/the Middle East/Africa, the Asia/Pacific, and North America/South America. Genius Group Limited was founded in 2002 and is headquartered in Singapore.

NewMarket stock logo

NewMarket NYSE:NEU

$789.88 +6.23 (+0.80%)
Closing price 03:59 PM Eastern
Extended Trading
$790.20 +0.32 (+0.04%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NewMarket Corporation, through its subsidiaries, primarily engages in the manufacture and sale of petroleum additives. The company offers lubricant additives for use in various vehicle and industrial applications, including engine oils, transmission fluids, off-road powertrain and hydraulic systems, gear oils, hydraulic oils, turbine oils, and other applications where metal-to-metal moving parts are utilized; engine oil additives designed for passenger cars, motorcycles, on and off-road heavy duty commercial equipment, locomotives, and engines in ocean-going vessels; driveline additives designed for products, such as transmission fluids, axle fluids, and off-road powertrain fluids; and industrial additives designed for products for industrial applications consisting of hydraulic fluids, grease, industrial gear fluids, and industrial specialty applications, such as turbine oils. It also provides fuel additives that are used to enhance the oil refining process and the performance of gasoline, diesel, biofuels, and other fuels to industry, government, original equipment manufacturers, and individual customers. In addition, the company engages in the marketing of antiknock compounds, as well as contracted manufacturing and services activities; and owns and manages a real property in Virginia. It operates in North America, Latin America, Asia Pacific, Europe, the Middle East, Africa, and India. NewMarket Corporation was founded in 1887 and is headquartered in Richmond, Virginia.

BeOne Medicines stock logo

BeOne Medicines NASDAQ:ONC

$327.03 +6.93 (+2.16%)
As of 04:00 PM Eastern

BeOne Medicines Ltd. is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. The firm portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in Basel, Switzerland.